Page last updated: 2024-10-29

ifosfamide and Sarcopenia

ifosfamide has been researched along with Sarcopenia in 2 studies

Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.

Research Excerpts

ExcerptRelevanceReference
"Eighteen patients (35."1.48Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin. ( Armento, G; Badalamenti, G; Catania, G; Incorvaia, L; Maltese, G; Napolitano, A; Santini, D; Silletta, M; Spalato Ceruso, M; Tonini, G; Valeri, S; Vincenzi, B, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kiyotoki, T1
Nakamura, K1
Haraga, J1
Omichi, C1
Ida, N1
Saijo, M1
Nishida, T1
Kusumoto, T1
Masuyama, H1
Vincenzi, B1
Badalamenti, G1
Armento, G1
Silletta, M1
Spalato Ceruso, M1
Catania, G1
Napolitano, A1
Maltese, G1
Valeri, S1
Incorvaia, L1
Santini, D1
Tonini, G1

Other Studies

2 other studies available for ifosfamide and Sarcopenia

ArticleYear
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2018, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cispl

2018
Body Mass Index as a Risk Factor for Toxicities in Patients with Advanced Soft-Tissue Sarcoma Treated with Trabectedin.
    Oncology, 2018, Volume: 95, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents, Alkylating; Antineoplastic Co

2018